![Peter Davies](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Davies
Direttore/Membro del Consiglio presso
Bionomics Ltd.
Patrimonio netto: 669 $ in data 31/05/2026
Profilo
Peter Miles Winston Davies is currently an Independent Non-Executive Director at Bionomics Ltd. since 2021, an Independent Non-Executive Director at Neuphoria Therapeutics, Inc. since 2024, and Chief Business Officer at Leaf4life, Inc. Formerly, Mr. Davies was Managing Director at Apeiron Investment Group Ltd. from 2021 to 2022.
Education includes graduation from The University of Edinburgh.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
0% | 20/01/2026 | 126 ( 0% ) | 669 $ | 31/05/2026 |
Posizioni attive di Peter Davies
| Società | Posizione | Inizio |
|---|---|---|
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Direttore/Membro del Consiglio | 01/07/2021 |
Leaf4life, Inc. | Corporate Officer/Principal | - |
Precedenti posizioni note di Peter Davies
| Società | Posizione | Fine |
|---|---|---|
Apeiron Investment Group Ltd.
 Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Investitore di Private Equity | 01/01/2022 |
Formazione di Peter Davies
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
3
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Bionomics Ltd.
Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apeiron Investment Group Ltd.
Apeiron Investment Group Ltd. Investment ManagersFinance Apeiron Investment Group invests in both public and private companies located across the globe primarily in the United States. The firm targets companies operating across a broad range of sectors and industries. It participates in pre-seed, seed, early, later and growth stage transactions. The firm invests in funds. It also acquires minority interest. | Finance |
Leaf4life, Inc. | Commercial Services |
